{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T12:00:01Z","timestamp":1790164801254,"version":"4.1.0"},"reference-count":108,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:00:00Z","timestamp":1790121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:00:00Z","timestamp":1790121600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Science, Technology & Innovation Funding Authority (STDF), Egypt; Post Graduate Support Grant (PGSG); Grant number: 48053","award":["48053"],"award-info":[{"award-number":["48053"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Biochem Biophys"],"DOI":"10.1007\/s12013-026-02158-1","type":"journal-article","created":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T09:24:28Z","timestamp":1790155468000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["\u201cL-Ornithine Liposomal Nanoparticles Targeting the Proline Cycle: A Mechanistic Perspective for Ammonia-Driven Hepatic Encephalopathy\u201d"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-0284-9714","authenticated-orcid":false,"given":"Amira","family":"Atta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9108-6932","authenticated-orcid":false,"given":"Maha M.","family":"Salem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarek M.","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,23]]},"reference":[{"issue":"4","key":"2158_CR1","doi-asserted-by":"publisher","first-page":"e22999","DOI":"10.1002\/dneu.22999","volume":"85","author":"U Kumar Dash","year":"2025","unstructured":"Kumar Dash, U., et al. (2025). Hepatic Encephalopathy: Insights Into the Impact of Metabolic Precipitates. Developmental Neurobiology, 85(4), e22999.","journal-title":"Developmental Neurobiology"},{"key":"2158_CR2","doi-asserted-by":"crossref","unstructured":"e Mustaffa, F. Exploring the Complexities of Hepatic Encephalopathy: Pathophysiology and Innovative Therapeutic Options. Prospects in Pharmaceutical Sciences, 2025(2025 (Early Access)).","DOI":"10.56782\/pps.402"},{"key":"2158_CR3","doi-asserted-by":"crossref","unstructured":"Roy, A., Dhiman, S., & Dhiman, R. K. (2025). Hepatic encephalopathy. Hepatology, : pp. 343\u2013370.","DOI":"10.1016\/B978-0-443-26710-9.00012-2"},{"issue":"1","key":"2158_CR4","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s43440-025-00786-7","volume":"78","author":"B El-Mansoury","year":"2026","unstructured":"El-Mansoury, B., et al. (2026). Current advances in the management of hepatic encephalopathy: an updated and critical review. Pharmacological Reports, 78(1), 173\u2013193.","journal-title":"Pharmacological Reports"},{"issue":"2","key":"2158_CR5","doi-asserted-by":"publisher","first-page":"3","DOI":"10.36283\/ziun-pjmd14-2\/002","volume":"14","author":"MA Samejo","year":"2025","unstructured":"Samejo, M. A., et al. (2025). Evaluation of Hepatic Encephalopathy Triggers and Outcomes in Chronic Liver Disease: A Regional Perspective. Pakistan Journal of Medicine and Dentistry, 14(2), 3\u20139.","journal-title":"Pakistan Journal of Medicine and Dentistry"},{"issue":"2","key":"2158_CR6","doi-asserted-by":"publisher","first-page":"loaf040","DOI":"10.1093\/lifemeta\/loaf040","volume":"5","author":"Z Lyu","year":"2026","unstructured":"Lyu, Z., et al. (2026). P5CS-coupled proline metabolism manipulates metabolic dysfunction-associated steatotic liver disease. Life Metabolism, 5(2), loaf040.","journal-title":"Life Metabolism"},{"issue":"6","key":"2158_CR7","doi-asserted-by":"publisher","first-page":"672","DOI":"10.3390\/life14060672","volume":"14","author":"MS Gatto","year":"2024","unstructured":"Gatto, M. S., Johnson, M. P., & Najahi-Missaoui, W. (2024). Targeted liposomal drug delivery: overview of the current applications and challenges. Life, 14(6), 672.","journal-title":"Life"},{"key":"2158_CR8","doi-asserted-by":"publisher","first-page":"148577","DOI":"10.1016\/j.ijbiomac.2025.148577","volume":"332","author":"MM Salem","year":"2025","unstructured":"Salem, M. M. (2025). L-ornithine liposomal nanoparticles as competitive inhibitor against \u22061-pyrroline-5-carboxylate dehydrogenase: Kinetic perspective hepatic encephalopathy therapy. International Journal of Biological Macromolecules, 332, 148577. https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.148577","journal-title":"International Journal of Biological Macromolecules"},{"issue":"4","key":"2158_CR9","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1111\/jnu.12969","volume":"56","author":"G Carlo Torres","year":"2024","unstructured":"Carlo Torres, G., et al. (2024). Adherence to PRISMA 2020 reporting guidelines and scope of systematic reviews published in nursing: A cross-sectional analysis. Journal of Nursing Scholarship, 56(4), 531\u2013541.","journal-title":"Journal of Nursing Scholarship"},{"issue":"1","key":"2158_CR10","first-page":"1","volume":"32","author":"Z Ahmed","year":"2023","unstructured":"Ahmed, Z. (2023). Comparative Efficacy of Treatment Options for the Prevention of Post-TIPS Hepatic Encephalopathy: A Systematic Review and Network Meta-analysis. Journal of Gastrointestinal & Liver Diseases, 32(1), 1\u201321.","journal-title":"Journal of Gastrointestinal &amp; Liver Diseases"},{"issue":"1","key":"2158_CR11","doi-asserted-by":"publisher","first-page":"4456","DOI":"10.1038\/s41467-023-40081-8","volume":"14","author":"Y Bai","year":"2023","unstructured":"Bai, Y., et al. (2023). Effects of oxidative stress on hepatic encephalopathy pathogenesis in mice. Nature Communications, 14(1), 4456.","journal-title":"Nature Communications"},{"issue":"5","key":"2158_CR12","doi-asserted-by":"publisher","first-page":"100593","DOI":"10.1016\/j.bj.2023.04.001","volume":"46","author":"SY Cheon","year":"2023","unstructured":"Cheon, S. Y., et al. (2023). Hyperammonemia induces microglial NLRP3 inflammasome activation via mitochondrial oxidative stress in hepatic encephalopathy. biomedical journal, 46(5), 100593.","journal-title":"biomedical journal"},{"issue":"5","key":"2158_CR13","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1007\/s12664-023-01412-1","volume":"42","author":"S Giri","year":"2023","unstructured":"Giri, S., et al. (2023). Prevalence of hepatic encephalopathy in patients with non-cirrhotic portal hypertension: A systematic review and meta-analysis. Indian Journal of Gastroenterology, 42(5), 642\u2013650.","journal-title":"Indian Journal of Gastroenterology"},{"issue":"1","key":"2158_CR14","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1007\/s11910-025-01415-9","volume":"25","author":"BK Sen","year":"2025","unstructured":"Sen, B. K., Pan, K., & Chakravarty, A. (2025). Hepatic encephalopathy: current thoughts on pathophysiology and management. Current neurology and neuroscience reports, 25(1), 28.","journal-title":"Current neurology and neuroscience reports"},{"key":"2158_CR15","doi-asserted-by":"publisher","first-page":"109526","DOI":"10.1016\/j.abb.2023.109526","volume":"736","author":"FF Lopes","year":"2023","unstructured":"Lopes, F. F., et al. (2023). Evaluation of oxidative damage to biomolecules and inflammation in patients with urea cycle disorders. Archives of Biochemistry and Biophysics, 736, 109526.","journal-title":"Archives of Biochemistry and Biophysics"},{"issue":"1","key":"2158_CR16","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/s41392-023-01569-3","volume":"8","author":"ZN Ling","year":"2023","unstructured":"Ling, Z. N., et al. (2023). Amino acid metabolism in health and disease. Signal Transduction and Targeted Therapy, 8(1), 345.","journal-title":"Signal Transduction and Targeted Therapy"},{"issue":"19","key":"2158_CR17","doi-asserted-by":"publisher","first-page":"3410","DOI":"10.3390\/plants12193410","volume":"12","author":"R Ingrisano","year":"2023","unstructured":"Ingrisano, R., et al. (2023). Proline, cysteine and branched-chain amino acids in abiotic stress response of land plants and microalgae. Plants, 12(19), 3410.","journal-title":"Plants"},{"key":"2158_CR18","doi-asserted-by":"publisher","first-page":"1118675","DOI":"10.3389\/fonc.2022.1118675","volume":"12","author":"JM Phang","year":"2023","unstructured":"Phang, J. M. (2023). The regulatory mechanisms of proline and hydroxyproline metabolism: Recent advances in perspective. Frontiers in Oncology, 12, 1118675.","journal-title":"Frontiers in Oncology"},{"issue":"2","key":"2158_CR19","doi-asserted-by":"publisher","first-page":"456","DOI":"10.3390\/cancers16020456","volume":"16","author":"MM Sawicka","year":"2024","unstructured":"Sawicka, M. M., et al. (2024). Proline Metabolism in WHO G4 Gliomas Is Altered as Compared to Unaffected Brain Tissue. Cancers, 16(2), 456.","journal-title":"Cancers"},{"issue":"6","key":"2158_CR20","doi-asserted-by":"publisher","first-page":"e12911","DOI":"10.1111\/jeu.12911","volume":"69","author":"A Z\u00edkov\u00e1","year":"2022","unstructured":"Z\u00edkov\u00e1, A. (2022). Mitochondrial adaptations throughout the Trypanosoma brucei life cycle. Journal of Eukaryotic Microbiology, 69(6), e12911.","journal-title":"Journal of Eukaryotic Microbiology"},{"issue":"2","key":"2158_CR21","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/s41416-019-0651-y","volume":"122","author":"V Raimondi","year":"2020","unstructured":"Raimondi, V., Ciccarese, F., & Ciminale, V. (2020). Oncogenic pathways and the electron transport chain: a dangeROS liaison. British journal of cancer, 122(2), 168\u2013181.","journal-title":"British journal of cancer"},{"key":"2158_CR22","doi-asserted-by":"crossref","unstructured":"Mailloux, R. J. (2023). Proline and dihydroorotate dehydrogenase promote a hyper-proliferative state and dampen ferroptosis in cancer cells by rewiring mitochondrial redox metabolism (p. 119639). Biochimica et Biophysica Acta (BBA)-Molecular Cell Research.","DOI":"10.1016\/j.bbamcr.2023.119639"},{"issue":"1","key":"2158_CR23","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1111\/tpj.15566","volume":"109","author":"P da Fonseca-Pereira","year":"2022","unstructured":"da Fonseca-Pereira, P., et al. (2022). The Arabidopsis electron\u2010transfer flavoprotein: ubiquinone oxidoreductase is required during normal seed development and germination. The Plant Journal, 109(1), 196\u2013214.","journal-title":"The Plant Journal"},{"issue":"3","key":"2158_CR24","doi-asserted-by":"publisher","first-page":"61","DOI":"10.31083\/j.fbl2803061","volume":"28","author":"W Jarmuszkiewicz","year":"2023","unstructured":"Jarmuszkiewicz, W., et al. (2023). Mitochondrial coenzyme Q redox homeostasis and reactive oxygen species production. Frontiers in Bioscience-Landmark, 28(3), 61.","journal-title":"Frontiers in Bioscience-Landmark"},{"issue":"4","key":"2158_CR25","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/s00726-021-03056-x","volume":"54","author":"S Hu","year":"2022","unstructured":"Hu, S., He, W., & Wu, G. (2022). Hydroxyproline in animal metabolism, nutrition, and cell signaling. Amino Acids, 54(4), 513\u2013528.","journal-title":"Amino Acids"},{"issue":"12","key":"2158_CR26","doi-asserted-by":"publisher","first-page":"7767","DOI":"10.1074\/jbc.M114.574525","volume":"290","author":"BS Mantilla","year":"2015","unstructured":"Mantilla, B. S., et al. (2015). Role of \u22061-pyrroline-5-carboxylate dehydrogenase supports mitochondrial metabolism and host-cell invasion of Trypanosoma cruzi. Journal of Biological Chemistry, 290(12), 7767\u20137790.","journal-title":"Journal of Biological Chemistry"},{"issue":"3","key":"2158_CR27","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1093\/jxb\/erad406","volume":"75","author":"Y Zheng","year":"2024","unstructured":"Zheng, Y., et al. (2024). Pyrroline-5-carboxylate metabolism protein complex detected in Arabidopsis thaliana leaf mitochondria. Journal of Experimental Botany, 75(3), 917\u2013934.","journal-title":"Journal of Experimental Botany"},{"issue":"47","key":"2158_CR28","doi-asserted-by":"publisher","first-page":"18443","DOI":"10.1021\/acs.jafc.3c06369","volume":"71","author":"S Huang","year":"2023","unstructured":"Huang, S., et al. (2023). l-Glutamate seed priming enhances 2-acetyl-1-pyrroline formation in fragrant rice seedlings in response to arsenite stress. Journal of Agricultural and Food Chemistry, 71(47), 18443\u201318453.","journal-title":"Journal of Agricultural and Food Chemistry"},{"issue":"1","key":"2158_CR29","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s40104-024-01100-w","volume":"15","author":"M Wang","year":"2024","unstructured":"Wang, M., et al. (2024). Proline metabolism is essential for alkaline adaptation of Nile tilapia (Oreochromis niloticus). Journal of Animal Science and Biotechnology, 15(1), 142.","journal-title":"Journal of Animal Science and Biotechnology"},{"issue":"9","key":"2158_CR30","doi-asserted-by":"publisher","first-page":"5111","DOI":"10.3390\/ijms23095111","volume":"23","author":"G Pallag","year":"2022","unstructured":"Pallag, G., et al. (2022). Proline oxidation supports mitochondrial ATP production when complex I is inhibited. International journal of molecular sciences, 23(9), 5111.","journal-title":"International journal of molecular sciences"},{"issue":"20","key":"2158_CR31","doi-asserted-by":"publisher","first-page":"6856","DOI":"10.1093\/jxb\/erab361","volume":"72","author":"Y Zheng","year":"2021","unstructured":"Zheng, Y., et al. (2021). The proline cycle as an eukaryotic redox valve. Journal of Experimental Botany, 72(20), 6856\u20136866.","journal-title":"Journal of Experimental Botany"},{"key":"2158_CR32","doi-asserted-by":"crossref","unstructured":"Kumar, S., Malviya, R., & Sundram, S. (2023). Nutritional neurology: Unraveling cellular mechanisms of natural supplements in brain health (p. 200232). Human Nutrition & Metabolism.","DOI":"10.1016\/j.hnm.2023.200232"},{"issue":"17","key":"2158_CR33","doi-asserted-by":"publisher","first-page":"6197","DOI":"10.3390\/ijms21176197","volume":"21","author":"R Dalangin","year":"2020","unstructured":"Dalangin, R., Kim, A., & Campbell, R. E. (2020). The role of amino acids in neurotransmission and fluorescent tools for their detection. International journal of molecular sciences, 21(17), 6197.","journal-title":"International journal of molecular sciences"},{"issue":"2","key":"2158_CR34","doi-asserted-by":"publisher","first-page":"230","DOI":"10.3390\/horticulturae9020230","volume":"9","author":"SA Dabravolski","year":"2023","unstructured":"Dabravolski, S. A., & Isayenkov, S. V. (2023). The role of the \u03b3-aminobutyric acid (GABA) in plant salt stress tolerance. Horticulturae, 9(2), 230.","journal-title":"Horticulturae"},{"key":"2158_CR35","doi-asserted-by":"publisher","first-page":"102808","DOI":"10.1016\/j.tice.2025.102808","volume":"94","author":"MM Salem","year":"2025","unstructured":"Salem, M. M., Elkeiy, M. M., El-Gamal, M. M., Saad-Allah, K. M., & Khamis, A. A. (2025). Evaluation of Paracentrotus lividus spines extract antioxidant, antidiabetic, anti-inflammatory, antimicrobial, and mechanistic anticancer: Insights into its composition using UPLC-ESI-MS-based metabolomic profiling. Tissue and Cell, 94, 102808.","journal-title":"Tissue and Cell"},{"issue":"1","key":"2158_CR36","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3390\/plants14010002","volume":"14","author":"M Renzetti","year":"2024","unstructured":"Renzetti, M., Funck, D., & Trovato, M. (2024). Proline and ROS: a unified mechanism in plant development and stress response? Plants, 14(1), 2.","journal-title":"Plants"},{"key":"2158_CR37","doi-asserted-by":"crossref","unstructured":"Choudhury, D. (2024). Proline restores mitochondrial function and reverses aging hallmarks in senescent cells. Cell Reports, 43(2).:1-20","DOI":"10.1016\/j.celrep.2024.113738"},{"key":"2158_CR38","doi-asserted-by":"crossref","unstructured":"Rathee, S., et al. (2026). Advances in understanding, diagnosing, and treating hepatic encephalopathy: from epidemiology to emerging therapies (pp. 1\u201322). Naunyn-Schmiedeberg\u2019s Archives of Pharmacology.","DOI":"10.1007\/s00210-025-04887-1"},{"key":"2158_CR39","doi-asserted-by":"crossref","unstructured":"Zhao, L., et al. (2022). Non-hepatic hyperammonemia: a potential therapeutic target for sepsis-associated encephalopathy (Vol. 21, pp. 738\u2013751). CNS & Neurological Disorders-Drug Targets-CNS & Neurological Disorders. 9.","DOI":"10.2174\/1871527321666211221161534"},{"issue":"3","key":"2158_CR40","doi-asserted-by":"publisher","first-page":"2937","DOI":"10.1007\/s12013-025-01678-6","volume":"83","author":"AA Khamis","year":"2025","unstructured":"Khamis, A. A., Elkeiy, M. M., El-Gamal, M. M., Saad-Allah, K. M., & Salem, M. M. (2025). Biological and Molecular Efficiency of Paracentrotus lividusShell in vitro Study: Antioxidant and Angiogenesis Effects Against T47DBreast Cancer Cell Line Via Nrf2\/HMOX-1\/and HIF-1\u03b1\/VEGF Signaling Pathways. Cell Biochemistry and Biophysics, 83(3), 2937\u20132959.","journal-title":"Cell Biochemistry and Biophysics"},{"key":"2158_CR41","doi-asserted-by":"publisher","first-page":"114477","DOI":"10.1016\/j.ab.2021.114477","volume":"636","author":"J Pelle","year":"2022","unstructured":"Pelle, J., et al. (2022). Metabolomics in the understanding and management of hepatic encephalopathy. Analytical Biochemistry, 636, 114477.","journal-title":"Analytical Biochemistry"},{"issue":"1","key":"2158_CR42","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1002\/fft2.180","volume":"4","author":"H Sati","year":"2023","unstructured":"Sati, H., Khandelwal, A., & Pareek, S. (2023). Effect of exogenous melatonin in fruit postharvest, crosstalk with hormones, and defense mechanism for oxidative stress management. Food Frontiers, 4(1), 233\u2013261.","journal-title":"Food Frontiers"},{"issue":"2","key":"2158_CR43","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.exppara.2011.07.006","volume":"129","author":"S Umair","year":"2011","unstructured":"Umair, S., et al. (2011). Enzymes of the ornithine\u2013glutamate\u2013proline pathway in the sheep abomasal nematode parasites Haemonchus contortus and Teladorsagia circumcincta. Experimental parasitology, 129(2), 115\u2013119.","journal-title":"Experimental parasitology"},{"key":"2158_CR44","unstructured":"Grossi, S. (2021). Study of regulatory factors in Non Small Cell Lung Cancer: a role for Proline Dehydrogenase?."},{"key":"2158_CR45","doi-asserted-by":"publisher","first-page":"672702","DOI":"10.3389\/fpls.2021.672702","volume":"12","author":"G Sabbioni","year":"2021","unstructured":"Sabbioni, G., Funck, D., & Forlani, G. (2021). Enzymology and regulation of \u03b41-pyrroline-5-carboxylate synthetase 2 from rice. Frontiers in Plant Science, 12, 672702.","journal-title":"Frontiers in Plant Science"},{"issue":"1","key":"2158_CR46","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1038\/s41418-020-0601-5","volume":"28","author":"Z Yang","year":"2021","unstructured":"Yang, Z., et al. (2021). Pyrroline-5-carboxylate synthase senses cellular stress and modulates metabolism by regulating mitochondrial respiration. Cell Death & Differentiation, 28(1), 303\u2013319.","journal-title":"Cell Death & Differentiation"},{"issue":"10","key":"2158_CR47","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.3390\/microorganisms10102077","volume":"10","author":"G Forlani","year":"2022","unstructured":"Forlani, G., Sabbioni, G., & Ruszkowski, M. (2022). Functional Characterization of Saccharomyces cerevisiae P5C Reductase, the Enzyme at the Converging Point of Proline and Arginine Metabolism. Microorganisms, 10(10), 2077.","journal-title":"Microorganisms"},{"issue":"5","key":"2158_CR48","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1111\/liv.14785","volume":"41","author":"C Formentin","year":"2021","unstructured":"Formentin, C., et al. (2021). Clinical, neuropsychological and neurophysiological indices and predictors of hepatic encephalopathy (HE). Liver international, 41(5), 1070\u20131082.","journal-title":"Liver international"},{"issue":"21","key":"2158_CR49","doi-asserted-by":"publisher","first-page":"11763","DOI":"10.3390\/ijms222111763","volume":"22","author":"M Chalecka","year":"2021","unstructured":"Chalecka, M., et al. (2021). P5C as an interface of proline interconvertible amino acids and its role in regulation of cell survival and apoptosis. International journal of molecular sciences, 22(21), 11763.","journal-title":"International journal of molecular sciences"},{"key":"2158_CR50","doi-asserted-by":"publisher","first-page":"100293","DOI":"10.1016\/j.cpb.2023.100293","volume":"35","author":"W Ying","year":"2023","unstructured":"Ying, W., et al. (2023). The correlation between proline\/P5C cycle and the response to avirulent pathogen infection in Arabidopsis. Current Plant Biology, 35, 100293.","journal-title":"Current Plant Biology"},{"key":"2158_CR51","doi-asserted-by":"publisher","first-page":"1013903","DOI":"10.3389\/fneur.2022.1013903","volume":"13","author":"Y Gan","year":"2022","unstructured":"Gan, Y., et al. (2022). Solute carrier transporter disease and developmental and epileptic encephalopathy. Frontiers in Neurology, 13, 1013903.","journal-title":"Frontiers in Neurology"},{"issue":"11","key":"2158_CR52","doi-asserted-by":"publisher","first-page":"781","DOI":"10.14348\/molcells.2022.0115","volume":"45","author":"Y Yao","year":"2022","unstructured":"Yao, Y., & Han, W. (2022). Proline metabolism in neurological and psychiatric disorders. Molecules and cells, 45(11), 781\u2013788.","journal-title":"Molecules and cells"},{"issue":"1","key":"2158_CR53","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1186\/s12870-024-05272-5","volume":"24","author":"U Ashraf","year":"2024","unstructured":"Ashraf, U., et al. (2024). Gamma amino butyric acid (GABA) application modulated the morpho-physiological and yield traits of fragrant rice under well-watered and drought conditions. BMC Plant Biology, 24(1), 569.","journal-title":"BMC Plant Biology"},{"issue":"5","key":"2158_CR54","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1007\/s10534-022-00415-3","volume":"35","author":"J Lu","year":"2022","unstructured":"Lu, J., et al. (2022). Metabolic changes of the reduction of manganese intake in the hepatic encephalopathy rat: NMR-and MS-based metabolomics study. Biometals, 35(5), 935\u2013953.","journal-title":"Biometals"},{"key":"2158_CR55","doi-asserted-by":"crossref","unstructured":"Baumgartner, M. R., Valle, D., & Dionisi-Vici, C. (2022). Disorders of ornithine and proline metabolism, in Inborn Metabolic Diseases: Diagnosis and Treatment (pp. 423\u2013436). Springer.","DOI":"10.1007\/978-3-662-63123-2_21"},{"key":"2158_CR56","doi-asserted-by":"publisher","first-page":"578922","DOI":"10.3389\/fnins.2021.578922","volume":"15","author":"ID Lim\u00f3n","year":"2021","unstructured":"Lim\u00f3n, I. D., et al. (2021). Disturbance of the glutamate-glutamine cycle, secondary to hepatic damage, compromises memory function. Frontiers in neuroscience, 15, 578922.","journal-title":"Frontiers in neuroscience"},{"issue":"4","key":"2158_CR57","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/s42255-023-00784-0","volume":"5","author":"SH Hu","year":"2023","unstructured":"Hu, S. H., et al. (2023). Amino acids downregulate SIRT4 to detoxify ammonia through the urea cycle. Nature metabolism, 5(4), 626\u2013641.","journal-title":"Nature metabolism"},{"issue":"3","key":"2158_CR58","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1111\/hepr.14022","volume":"54","author":"K Katayama","year":"2024","unstructured":"Katayama, K., & Kakita, N. (2024). Possible pathogenetic role of ammonia in liver cirrhosis without hyperammonemia of venous blood: The so-called latency period of abnormal ammonia metabolism. Hepatology Research, 54(3), 235\u2013243.","journal-title":"Hepatology Research"},{"key":"2158_CR59","doi-asserted-by":"publisher","first-page":"646291","DOI":"10.3389\/fnins.2021.646291","volume":"15","author":"CM Voss","year":"2021","unstructured":"Voss, C. M., et al. (2021). Glutamate dehydrogenase is important for ammonia fixation and amino acid homeostasis in brain during hyperammonemia. Frontiers in Neuroscience, 15, 646291.","journal-title":"Frontiers in Neuroscience"},{"issue":"1","key":"2158_CR60","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1007\/s12672-026-04708-8","volume":"17","author":"MM Salem","year":"2026","unstructured":"Salem, M. M., & Mohamed, T. M. (2026). Targeting cancer signaling pathways and their therapeutic strategies. Discover Oncology, 17(1), 548.","journal-title":"Discover Oncology"},{"key":"2158_CR61","doi-asserted-by":"publisher","first-page":"105198","DOI":"10.1016\/j.nbd.2020.105198","volume":"148","author":"JV Andersen","year":"2021","unstructured":"Andersen, J. V., et al. (2021). Deficient astrocyte metabolism impairs glutamine synthesis and neurotransmitter homeostasis in a mouse model of Alzheimer\u2019s disease. Neurobiology of disease, 148, 105198.","journal-title":"Neurobiology of disease"},{"issue":"11","key":"2158_CR62","doi-asserted-by":"publisher","first-page":"5088","DOI":"10.1021\/acs.jproteome.1c00620","volume":"20","author":"D Dubey","year":"2021","unstructured":"Dubey, D., et al. (2021). NMR-based metabolomics revealed the underlying inflammatory pathology in reactive arthritis synovial joints. Journal of Proteome Research, 20(11), 5088\u20135102.","journal-title":"Journal of Proteome Research"},{"issue":"4","key":"2158_CR63","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1007\/s10811-023-03017-9","volume":"35","author":"S Barera","year":"2023","unstructured":"Barera, S., & Forlani, G. (2023). The role of proline in the adaptation of eukaryotic microalgae to environmental stress: An underestimated tool for the optimization of algal growth. Journal of Applied Phycology, 35(4), 1635\u20131648.","journal-title":"Journal of Applied Phycology"},{"key":"2158_CR64","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s11010-020-03685-y","volume":"466","author":"TYL Huynh","year":"2020","unstructured":"Huynh, T. Y. L., et al. (2020). Understanding the role of key amino acids in regulation of proline dehydrogenase\/proline oxidase (prodh\/pox)-dependent apoptosis\/autophagy as an approach to targeted cancer therapy. Molecular and cellular biochemistry, 466, 35\u201344.","journal-title":"Molecular and cellular biochemistry"},{"issue":"1","key":"2158_CR65","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1080\/14756366.2021.1919890","volume":"36","author":"G Forlani","year":"2021","unstructured":"Forlani, G., et al. (2021). Phenyl-substituted aminomethylene-bisphosphonates inhibit human P5C reductase and show antiproliferative activity against proline-hyperproducing tumour cells. Journal of enzyme inhibition and medicinal chemistry, 36(1), 1248\u20131257.","journal-title":"Journal of enzyme inhibition and medicinal chemistry"},{"issue":"2","key":"2158_CR66","doi-asserted-by":"publisher","first-page":"e70185","DOI":"10.1111\/eci.70185","volume":"56","author":"A Ismaiel","year":"2026","unstructured":"Ismaiel, A., et al. (2026). Can ammonia scavenging treat MASLD? Evaluating the evidence for L-ornithine L\u2010aspartate\u2014A systematic review. European Journal of Clinical Investigation, 56(2), e70185.","journal-title":"European Journal of Clinical Investigation"},{"issue":"12","key":"2158_CR67","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1080\/13543784.2024.2434053","volume":"33","author":"A Gil-G\u00f3mez","year":"2024","unstructured":"Gil-G\u00f3mez, A., et al. (2024). Hepatic encephalopathy: experimental drugs in development and therapeutic potential. Expert Opinion on Investigational Drugs, 33(12), 1219\u20131230.","journal-title":"Expert Opinion on Investigational Drugs"},{"issue":"2","key":"2158_CR68","doi-asserted-by":"publisher","first-page":"356","DOI":"10.14218\/JCTH.2021.00247","volume":"10","author":"\u00c1 Rojas","year":"2022","unstructured":"Rojas, \u00c1., et al. (2022). Glutaminolysis-ammonia-urea cycle axis, non-alcoholic fatty liver disease progression and development of novel therapies. Journal of Clinical and Translational Hepatology, 10(2), 356.","journal-title":"Journal of Clinical and Translational Hepatology"},{"issue":"Suppl 1","key":"2158_CR69","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s40265-018-1020-5","volume":"79","author":"A Canbay","year":"2019","unstructured":"Canbay, A., & Sowa, J. P. (2019). L-Ornithine L-Aspartate (LOLA) as a novel approach for therapy of non-alcoholic fatty liver disease. Drugs, 79(Suppl 1), 39\u201344.","journal-title":"Drugs"},{"issue":"3","key":"2158_CR70","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.jceh.2018.05.004","volume":"8","author":"RF Butterworth","year":"2018","unstructured":"Butterworth, R. F., et al. (2018). Efficacy of l-ornithine l-aspartate for the treatment of hepatic encephalopathy and hyperammonemia in cirrhosis: systematic review and meta-analysis of randomized controlled trials. Journal of clinical and experimental hepatology, 8(3), 301\u2013313.","journal-title":"Journal of clinical and experimental hepatology"},{"issue":"1","key":"2158_CR71","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1159\/000491429","volume":"37","author":"RF Butterworth","year":"2018","unstructured":"Butterworth, R. F., & Canbay, A. (2018). Hepatoprotection by L-ornithine L-aspartate in non-alcoholic fatty liver disease. Digestive Diseases, 37(1), 63\u201368.","journal-title":"Digestive Diseases"},{"key":"2158_CR72","doi-asserted-by":"publisher","first-page":"102757","DOI":"10.1016\/j.cis.2022.102757","volume":"309","author":"M Dymek","year":"2022","unstructured":"Dymek, M., & Sikora, E. (2022). Liposomes as biocompatible and smart delivery systems\u2013the current state. Advances in colloid and interface science, 309, 102757.","journal-title":"Advances in colloid and interface science"},{"issue":"4","key":"2158_CR73","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.3390\/molecules27041372","volume":"27","author":"P Liu","year":"2022","unstructured":"Liu, P., Chen, G., & Zhang, J. (2022). A review of liposomes as a drug delivery system: current status of approved products, regulatory environments, and future perspectives. Molecules, 27(4), 1372.","journal-title":"Molecules"},{"key":"2158_CR74","doi-asserted-by":"publisher","first-page":"112737","DOI":"10.1016\/j.colsurfb.2022.112737","volume":"218","author":"V De Leo","year":"2022","unstructured":"De Leo, V., et al. (2022). Liposomes containing nanoparticles: preparation and applications. Colloids and Surfaces B: Biointerfaces, 218, 112737.","journal-title":"Colloids and Surfaces B: Biointerfaces"},{"issue":"7","key":"2158_CR75","doi-asserted-by":"publisher","first-page":"6615","DOI":"10.3390\/ijms24076615","volume":"24","author":"MD Fulton","year":"2023","unstructured":"Fulton, M. D., & Najahi-Missaoui, W. (2023). Liposomes in cancer therapy: how did we start and where are we now. International Journal of Molecular Sciences, 24(7), 6615.","journal-title":"International Journal of Molecular Sciences"},{"issue":"1","key":"2158_CR76","first-page":"7","volume":"13","author":"H Abbasi","year":"2023","unstructured":"Abbasi, H., et al. (2023). What we need to know about liposomes as drug nanocarriers: an updated review. Advanced pharmaceutical bulletin, 13(1), 7.","journal-title":"Advanced pharmaceutical bulletin"},{"issue":"1","key":"2158_CR77","doi-asserted-by":"publisher","first-page":"294","DOI":"10.3390\/pharmaceutics15010294","volume":"15","author":"YN Al Badri","year":"2023","unstructured":"Al Badri, Y. N., Chaw, C. S., & Elkordy, A. A. (2023). Insights into asymmetric liposomes as a potential intervention for drug delivery including pulmonary nanotherapeutics. Pharmaceutics, 15(1), 294.","journal-title":"Pharmaceutics"},{"issue":"3","key":"2158_CR78","doi-asserted-by":"publisher","first-page":"22","DOI":"10.22159\/ijap.2024v16i3.50601","volume":"16","author":"D SIVADASAN","year":"2024","unstructured":"SIVADASAN, D. (2024). AND ITS ABILITY TO EVADE THE IMMUNE SYSTEM: A NEW FRONTIER IN CANCER CHEMOTHERAPY. Int J App Pharm, 16(3), 22\u201336. AN UPDATED REVIEW OF STEALTH LIPOSOMES.","journal-title":"Int J App Pharm"},{"key":"2158_CR79","doi-asserted-by":"publisher","first-page":"114895","DOI":"10.1016\/j.addr.2023.114895","volume":"198","author":"P Wen","year":"2023","unstructured":"Wen, P., et al. (2023). Stealth and pseudo-stealth nanocarriers. Advanced drug delivery reviews, 198, 114895.","journal-title":"Advanced drug delivery reviews"},{"issue":"2","key":"2158_CR80","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1080\/08982104.2023.2268710","volume":"34","author":"Y Fidan","year":"2024","unstructured":"Fidan, Y., et al. (2024). Recent advances in liposome-based targeted cancer therapy. Journal of Liposome Research, 34(2), 316\u2013334.","journal-title":"Journal of Liposome Research"},{"key":"2158_CR81","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.bioactmat.2022.12.027","volume":"24","author":"J Nel","year":"2023","unstructured":"Nel, J., et al. (2023). Functionalized liposomes for targeted breast cancer drug delivery. Bioactive materials, 24, 401\u2013437.","journal-title":"Bioactive materials"},{"issue":"5","key":"2158_CR82","doi-asserted-by":"publisher","first-page":"103550","DOI":"10.1016\/j.drudis.2023.103550","volume":"28","author":"D Sanjanwala","year":"2023","unstructured":"Sanjanwala, D., & Patravale, V. (2023). Aptamers and nanobodies as alternatives to antibodies for ligand-targeted drug delivery in cancer. Drug Discovery Today, 28(5), 103550.","journal-title":"Drug Discovery Today"},{"key":"2158_CR83","doi-asserted-by":"publisher","first-page":"102930","DOI":"10.1016\/j.cis.2023.102930","volume":"317","author":"S Kans\u0131z","year":"2023","unstructured":"Kans\u0131z, S., & El\u00e7in, Y. M. (2023). Advanced liposome and polymersome-based drug delivery systems: Considerations for physicochemical properties, targeting strategies and stimuli-sensitive approaches. Advances in Colloid and Interface Science, 317, 102930.","journal-title":"Advances in Colloid and Interface Science"},{"key":"2158_CR84","doi-asserted-by":"crossref","unstructured":".Rao, M.J., Murugaiyan, K. and Rengan, A.K., 2024. Thermoresponsive Micro and Nano Drug Delivery Systems. In Smart Micro-and Nanomaterials for Drug Delivery (pp. 206-221). CRC Press","DOI":"10.1201\/9781003468424-11"},{"issue":"1","key":"2158_CR85","doi-asserted-by":"publisher","first-page":"3267","DOI":"10.1038\/s41598-025-34562-7","volume":"16","author":"MM Salem","year":"2026","unstructured":"Salem, M. M., Khattab, A. T., Beltagy, D. M., & El-Keiy, M. M. (2026). Synergistic therapeutic impact of dichloroacetate nanoparticles and doxorubicin in modulating pyruvate dehydrogenase kinase in breast carcinoma model. Scientific Reports, 16(1), 3267.","journal-title":"Scientific Reports"},{"key":"2158_CR86","unstructured":"Wang, H. (2024). Design and synthesis of renewable lipid-based nanocarriers with thermosensitivity for targeted drug delivery applications."},{"key":"2158_CR87","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.jconrel.2019.08.011","volume":"310","author":"LB Vong","year":"2019","unstructured":"Vong, L. B., et al. (2019). Poly (ornithine)-based self-assembling drug for recovery of hyperammonemia and damage in acute liver injury. Journal of controlled release, 310, 74\u201381.","journal-title":"Journal of controlled release"},{"issue":"16","key":"2158_CR88","doi-asserted-by":"publisher","first-page":"6038","DOI":"10.3390\/molecules28166038","volume":"28","author":"Q Xie","year":"2023","unstructured":"Xie, Q., et al. (2023). Recent Progress of Preparation Strategies in Organic Nanoparticles for Cancer Phototherapeutics. Molecules, 28(16), 6038.","journal-title":"Molecules"},{"issue":"2","key":"2158_CR89","doi-asserted-by":"publisher","first-page":"699","DOI":"10.3390\/pharmaceutics15020699","volume":"15","author":"TF Rakotondrabe","year":"2023","unstructured":"Rakotondrabe, T. F., et al. (2023). Modulating inflammation-mediated diseases via natural phenolic compounds loaded in nanocarrier systems. Pharmaceutics, 15(2), 699.","journal-title":"Pharmaceutics"},{"key":"2158_CR90","doi-asserted-by":"publisher","first-page":"103656","DOI":"10.1016\/j.jddst.2022.103656","volume":"75","author":"KT Sastri","year":"2022","unstructured":"Sastri, K. T., et al. (2022). Nanocarrier facilitated drug delivery to the brain through intranasal route: a promising approach to transcend bio-obstacles and alleviate neurodegenerative conditions. Journal of Drug Delivery Science and Technology, 75, 103656.","journal-title":"Journal of Drug Delivery Science and Technology"},{"key":"2158_CR91","doi-asserted-by":"publisher","first-page":"215251","DOI":"10.1016\/j.ccr.2023.215251","volume":"491","author":"Y Dutt","year":"2023","unstructured":"Dutt, Y., et al. (2023). Liposomes and phytosomes: nanocarrier systems and their applications for the delivery of phytoconstituents. Coordination Chemistry Reviews, 491, 215251.","journal-title":"Coordination Chemistry Reviews"},{"key":"2158_CR92","doi-asserted-by":"publisher","first-page":"102332","DOI":"10.1016\/j.tice.2024.102332","volume":"87","author":"FM El-Demerdash","year":"2024","unstructured":"El-Demerdash, F. M., Al Mhanna, A. B., El-Sayed, R. A., Mohamed, T. M., & Salem, M. M. (2024). Hepatoprotective impact of Nigella sativa silver nanocomposite against genotoxicity, oxidative stress, and inflammation induced by thioacetamide. Tissue and Cell, 87, 102332.","journal-title":"Tissue and Cell"},{"issue":"1","key":"2158_CR93","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s12013-025-01929-6","volume":"84","author":"AT Khattab","year":"2026","unstructured":"Khattab, A. T., El-Keey, M. M., Beltagy, D. M., & Salem, M. M. (2026). Revolutionizing breast cancer treatment: Harnessing Ehrlich ascites carcinoma model, cancer metabolism, and nanotechnology-enhanced chemotherapy for improved patient outcomes. Cell Biochemistry and Biophysics, 84(1), 341\u2013360.","journal-title":"Cell Biochemistry and Biophysics"},{"issue":"2","key":"2158_CR94","doi-asserted-by":"publisher","first-page":"786","DOI":"10.3390\/ijms25020786","volume":"25","author":"M Jamro\u017cy","year":"2024","unstructured":"Jamro\u017cy, M., et al. (2024). Advanced Drug Carriers: A Review of Selected Protein, Polysaccharide, and Lipid Drug Delivery Platforms. International Journal of Molecular Sciences, 25(2), 786.","journal-title":"International Journal of Molecular Sciences"},{"issue":"2","key":"2158_CR95","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1007\/s12013-024-01626-w","volume":"83","author":"A Atta","year":"2025","unstructured":"Atta, A., Salem, M. M., Reda, A., & Mohamed, T. M. (2025). Carnosine-Niosomal Delivery System for Targeted Cancer Therapy. Cell Biochemistry and Biophysics, 83(2), 1495\u20131520.","journal-title":"Cell Biochemistry and Biophysics"},{"issue":"6","key":"2158_CR96","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.4103\/1673-5374.327328","volume":"17","author":"C Hernandez","year":"2022","unstructured":"Hernandez, C., & Shukla, S. (2022). Liposome based drug delivery as a potential treatment option for Alzheimer\u2019s disease. Neural regeneration research, 17(6), 1190\u20131198.","journal-title":"Neural regeneration research"},{"issue":"1","key":"2158_CR97","doi-asserted-by":"publisher","first-page":"28859","DOI":"10.1038\/s41598-024-79992-x","volume":"14","author":"AA Noser","year":"2024","unstructured":"Noser, A. A., Salem, M. M., Baren, M. H., Selim, A. I., & ElSafty, E. M. (2024). Discovering the inhibition of YAP\/TEAD Hippo signaling pathway vianew pyrazolone derivatives: synthesis, molecular docking and biologicalinvestigations. Scientific Reports, 14(1), 28859.","journal-title":"Scientific Reports"},{"key":"2158_CR98","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12929-020-00702-6","volume":"28","author":"A Pant","year":"2021","unstructured":"Pant, A., Mackraj, I., & Govender, T. (2021). Advances in sepsis diagnosis and management: a paradigm shift towards nanotechnology. Journal of Biomedical Science, 28, 1\u201330.","journal-title":"Journal of Biomedical Science"},{"issue":"5","key":"2158_CR99","doi-asserted-by":"publisher","first-page":"2100639","DOI":"10.1002\/adhm.202100639","volume":"11","author":"L van der Koog","year":"2022","unstructured":"van der Koog, L., Gandek, T. B., & Nagelkerke, A. (2022). Liposomes and extracellular vesicles as drug delivery systems: A comparison of composition, pharmacokinetics, and functionalization. Advanced healthcare materials, 11(5), 2100639.","journal-title":"Advanced healthcare materials"},{"key":"2158_CR100","doi-asserted-by":"crossref","unstructured":"Noser, A. A., Baren, M. H., Ibrahim, S. A., Rekaby, M., & Salem, M. M. (2023). New pyrazolothiazole as potential wnt\/\u03b2\u2010catenin inhibitors: green synthesis, characterization, antimicrobial, antioxidant, antineoplasticevaluation, and molecular docking study. ChemistrySelect, 8(12), e202204670.","DOI":"10.1002\/slct.202204670"},{"key":"2158_CR101","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.addr.2021.01.019","volume":"174","author":"S Antimisiaris","year":"2021","unstructured":"Antimisiaris, S., et al. (2021). Overcoming barriers by local drug delivery with liposomes. Advanced drug delivery reviews, 174, 53\u201386.","journal-title":"Advanced drug delivery reviews"},{"key":"2158_CR102","doi-asserted-by":"publisher","first-page":"114396","DOI":"10.1016\/j.addr.2022.114396","volume":"188","author":"H Haroon","year":"2022","unstructured":"Haroon, H., et al. (2022). A brief history of long circulating nanoparticles. Advanced Drug Delivery Reviews, 188, 114396.","journal-title":"Advanced Drug Delivery Reviews"},{"issue":"1","key":"2158_CR103","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s11671-021-03553-8","volume":"16","author":"F Rommasi","year":"2021","unstructured":"Rommasi, F., & Esfandiari, N. (2021). Liposomal nanomedicine: applications for drug delivery in cancer therapy. Nanoscale Research Letters, 16(1), 95.","journal-title":"Nanoscale Research Letters"},{"issue":"2","key":"2158_CR104","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1134\/S1990747823030054","volume":"17","author":"Z Denieva","year":"2023","unstructured":"Denieva, Z., et al. (2023). Mixed cationic liposomes based on L-amino acids as efficient delivery systems of therapeutic molecules into cells. Biochemistry (Moscow) Supplement Series A: Membrane and Cell Biology, 17(2), 136\u2013147.","journal-title":"Biochemistry (Moscow) Supplement Series A: Membrane and Cell Biology"},{"issue":"12","key":"2158_CR105","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1007\/s00726-021-02981-1","volume":"53","author":"J Du","year":"2021","unstructured":"Du, J., et al. (2021). Proline metabolism and transport in retinal health and disease. Amino acids, 53(12), 1789\u20131806.","journal-title":"Amino acids"},{"issue":"9","key":"2158_CR106","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1177\/1535370221989263","volume":"246","author":"SM Sears","year":"2021","unstructured":"Sears, S. M., & Hewett, S. J. (2021). Influence of glutamate and GABA transport on brain excitatory\/inhibitory balance. Experimental Biology and Medicine, 246(9), 1069\u20131083.","journal-title":"Experimental Biology and Medicine"},{"key":"2158_CR107","doi-asserted-by":"publisher","first-page":"102331","DOI":"10.1016\/j.pneurobio.2022.102331","volume":"217","author":"JV Andersen","year":"2022","unstructured":"Andersen, J. V., Schousboe, A., & Verkhratsky, A. (2022). Astrocyte energy and neurotransmitter metabolism in Alzheimer\u2019s disease: integration of the glutamate\/GABA-glutamine cycle. Progress in neurobiology, 217, 102331.","journal-title":"Progress in neurobiology"},{"issue":"1","key":"2158_CR108","doi-asserted-by":"publisher","first-page":"18430","DOI":"10.1038\/s41598-021-97855-7","volume":"11","author":"M Ferrario","year":"2021","unstructured":"Ferrario, M., et al. (2021). Persistent hyperammonia and altered concentrations of urea cycle metabolites in a 5-day swine experiment of sepsis. Scientific reports, 11(1), 18430.","journal-title":"Scientific reports"}],"container-title":["Cell Biochemistry and Biophysics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12013-026-02158-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12013-026-02158-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12013-026-02158-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T11:03:38Z","timestamp":1790161418000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12013-026-02158-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,23]]},"references-count":108,"alternative-id":["2158"],"URL":"https:\/\/doi.org\/10.1007\/s12013-026-02158-1","relation":{},"ISSN":["1559-0283"],"issn-type":[{"value":"1559-0283","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,23]]},"assertion":[{"value":"17 August 2026","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of Interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}